Frequent STAT5B mutations in γδ hepatosplenic T-cell lymphomas

[1]  K. Elenitoba-Johnson,et al.  Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia. , 2014, Blood.

[2]  A. Trumpp,et al.  Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit. , 2014, Cell stem cell.

[3]  PavlakiKonstantia,et al.  Impaired proliferative potential of bone marrow mesenchymal stromal cells in patients with myelodysplastic syndromes is associated with abnormal WNT signaling pathway. , 2014 .

[4]  O. Lohi,et al.  Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia , 2014, Leukemia.

[5]  J. Qi,et al.  Targeting STAT5 in Hematologic Malignancies through Inhibition of the Bromodomain and Extra-Terminal (BET) Bromodomain Protein BRD2 , 2014, Molecular Cancer Therapeutics.

[6]  J. Qi,et al.  Targeting STAT 5 in Hematologic Malignancies through Inhibition of the Bromodomain and Extra-Terminal ( BET ) Bromodomain Protein BRD 2 , 2014 .

[7]  P. Lollini,et al.  An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas , 2014, BMC Cancer.

[8]  J. Merker,et al.  STAT3 mutations are frequent in CD30+ T-cell lymphomas and T-cell large granular lymphocytic leukemia , 2013, Leukemia.

[9]  F. Alesiani,et al.  Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes , 2013, European journal of haematology.

[10]  S. Mustjoki,et al.  Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia. , 2013, Blood.

[11]  S. Mustjoki,et al.  STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia. , 2012, Blood.

[12]  P. Gaulard,et al.  Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets. , 2012, Blood.

[13]  S. Mustjoki,et al.  Somatic STAT3 mutations in large granular lymphocytic leukemia. , 2012, The New England journal of medicine.

[14]  M. Farrar,et al.  The role of STAT5 in lymphocyte development and transformation. , 2012, Current opinion in immunology.

[15]  N. Golestaneh,et al.  STAT3 Protein Promotes T-cell Survival and Inhibits Interleukin-2 Production through Up-regulation of Class O Forkhead Transcription Factors* , 2011, The Journal of Biological Chemistry.

[16]  P. Leoni,et al.  Human Mesenchymal Stem Cells from Chorionic Villi and Amniotic Fluid are not Susceptible to Transformation after Extensive in Vitro Expansion , 2011, Cell transplantation.

[17]  B. Ebert,et al.  The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors. , 2011, Blood.

[18]  Carmen Koch,et al.  How to track cellular aging of mesenchymal stromal cells? , 2010, Aging.

[19]  Florian Nolte,et al.  Myelodysplastic syndromes: molecular pathogenesis and genomic changes , 2008, Annals of Hematology.

[20]  L. Ricci-Vitiani,et al.  Loss of pericentromeric DNA methylation pattern in human glioblastoma is associated with altered DNA methyltransferases expression and involves the stem cell compartment , 2008, Oncogene.

[21]  W. Leonard,et al.  A Stat5b transgene is capable of inducing CD8+ lymphoblastic lymphoma in the absence of normal TCR/MHC signaling. , 2008, Blood.

[22]  U. Lehmann,et al.  [Methylation status of LINE-1 sequences in patients with MDS or secondary AML]. , 2007, Verhandlungen der Deutschen Gesellschaft fur Pathologie.

[23]  A. Órfão,et al.  TCRγδ+ large granular lymphocyte leukemias reflect the spectrum of normal antigen-selected TCRγδ+ T-cells , 2006, Leukemia.

[24]  A. Tagliabracci,et al.  Engraftment capacity of mesenchymal cells following hematopoietic stem cell transplantation in patients receiving reduced-intensity conditioning regimen , 2006, Leukemia.

[25]  A. Órfão,et al.  TCRgammadelta+ large granular lymphocyte leukemias reflect the spectrum of normal antigen-selected TCRgammadelta+ T-cells. , 2006, Leukemia.

[26]  S. John,et al.  Signal transducer and activator of transcription (STAT) signalling and T‐cell lymphomas , 2005, Immunology.

[27]  R. Berger,et al.  Isochromosome 7q and trisomy 8 are consistent primary, non-random chromosomal abnormalities associated with hepatosplenic T gamma/delta lymphoma. , 1996, Leukemia.